Resultados de la búsqueda 91-100 de 3018 para anti-TNF drugs

1. Untitled

   Page 1.

2. Hematología - Ensayos clínicos - Mayo Clinic

   Targeted drug therapies have greatly improved outcomes for patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) and non-Hodgkin's ...

3. Neurología - Ensayos clínicos - Mayo Clinic

   ... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...

4. Neurología - Ensayos clínicos - Mayo Clinic

   ... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...

5. Hematología - Ensayos clínicos - Mayo Clinic

   Targeted drug therapies have greatly improved outcomes for patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) and non-Hodgkin's ...

6. Cardo mariano - Mayo Clinic

   Natural Medicines. https://naturalmedicines.therapeuticresearch.com. Accessed Oct. 30, 2020. Pizzorono JE, et al., eds. Silybum marianum (milk thistle). In ...

7. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

   ... therapy medication as prescribed (medication adherence). Testing the Addition of an Anti-cancer Drug, ASTX727, to Chemotherapy (Paclitaxel) and ...

8. Obstetricia y Ginecología - Ensayos clínicos - Mayo Clinic

   Olaparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as temozolomide, work in ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with ALL therapy ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with ALL therapy ...